•
Dec 30, 2024

Soleno Therapeutics Q4 2024 Earnings Report

Expected Revenue:$0
Expected EPS:-$0.63
103.2% YoY
Total Revenue
$0
Previous year: $3.45M
-100.0%
Gross Profit
-$503K
0
Cash and Equivalents
$291M
Previous year: $170M
+71.7%
Free Cash Flow
-$24M
Previous year: -$6.31M
+280.1%
Total Assets
$331M
Previous year: $181M
+83.2%

Soleno Therapeutics

Soleno Therapeutics